Cerba Research continues to monitor the global COVID-19 pandemic. We have an established team of experts who review our business operations on a daily basis and implement actions to respond to changes in the global environment.
We are committed to ensuring business continuity to support our Biomarkers services, Clinical Trials Laboratory services, and In-Vitro Diagnostics services and ensure the well-being and safety of our employees, our customers, investigator sites, and patients.
We continue to review the updated guidance from the World Health Organization (WHO), the Centers for Disease Control (CDC), and national and government organizations, and adapt our business continuity and service offerings as the situation evolves.
We have taken the following actions to mitigate risk and maintain business continuity:
Flexible and home working arrangements for all office-based employees in all our affiliates
Our employees’ health and safety is priority. All employees have received training and guidance on personal protection measures. Employees whose functions allow it are instructed to work from home. For employees who have to work from the office, hygiene and social distancing measures are in place and instructions displayed in key areas of our offices. Employees with symptoms or contact persons are advised to get tested and to self-isolate until the test results are confirmed negative.
Additional precautions for those at greater risk
For our sample handling, kit building, logistics, warehouse, and laboratory staff, additional safety measures and rotational working arrangements have been implemented. We have also implemented a travel advisory and employees will not be permitted to travel unless required due to extreme circumstances.
Comprehensive systems oversight, full contingency planning
We continue to monitor courier services and contingency plans to minimize any disruption to our customer base. We have confirmed all couriers have contingency plans in place and are using all necessary means to offer service. We are enacting our own contingency plans to ensure we have solutions should the current/standard courier be unable to deliver. In the event there are impacted areas within a country where couriers are not able to access sites due to government mandated closures, we will provide updates to sites via the local courier offices and communicate updates to sites and customers.
Regular updates, consistent communication
All sites are directed to check the Cerba Research website for the latest information related to our operational services. Regular internal and external updates will be provided as needed as we continue to monitor the situation.
If you have any questions or require assistance, please contact your Cerba Research Project Manager.
Cerba Research continues to implement processes to ensure smooth running of all translational science, central laboratory, and in-vitro diagnostics services during this time. These processes are focused on the well-being and safety of our employees, our customers, investigator sites, and study participants.